Artificial neural network prediction of antisense oligodeoxynucleotide activity

被引:22
作者
Giddings, MC
Shah, AA
Freier, S
Atkins, JF
Gesteland, RF
Matveeva, OV
机构
[1] Univ Utah, Dept Human Genet, SLC, Salt Lake City, UT 84112 USA
[2] ISIS Pharmaceut, Carlsbad, CA 92008 USA
关键词
D O I
10.1093/nar/gkf557
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An mRNA transcript contains many potential antisense oligodeoxynucleotide target sites. Identifi cation of the most efficacious targets remains an important and challenging problem. Building on separate work that revealed a strong correlation between the inclusion of short sequence motifs and the activity level of an oligo, we have developed a predictive artificial neural network system for mapping tetranucleotide motif content to antisense oligo activity. Trained for high-specificity prediction, the system has been cross-validated against a database of 348 oligos from the literature and a larger proprietary database of 908 oligos. In cross- validation tests the system identified effective oligos (i.e. oligos capable of reducing target mRNA expression to <25% that of the control) with 53% accuracy, in contrast to the <10% success rates commonly reported for trial-and-error oligo selection, suggesting a possible 5-fold reduction in the in vivo screening required to find an active oligo. We have implemented a web interface to a trained neural network. Given an RNA transcript as input, the system identifies the most likely oligo targets and provides estimates of the probabilities that oligos targeted against these sites will be effective.
引用
收藏
页码:4295 / 4304
页数:10
相关论文
共 28 条
[1]  
BENNETT CF, 1994, J IMMUNOL, V152, P3530
[2]   A good antisense molecule is hard to find [J].
Branch, AD .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (02) :45-50
[3]  
CHIANG MY, 1991, J BIOL CHEM, V266, P18162
[4]  
Fahlman S.E., 1988, An Empirical Study of Learning Speed in Back-Propagation Networks
[5]  
Geiger T, 1997, CLIN CANCER RES, V3, P1179
[6]   Myb targeted therapeutics for the treatment of human malignancies [J].
Gewirtz, AM .
ONCOGENE, 1999, 18 (19) :3056-3062
[7]   ODNBase - a web database for antisense oligonucleotide effectiveness studies [J].
Giddings, MC ;
Matveeva, OV ;
Atkins, JF ;
Gesteland, RF .
BIOINFORMATICS, 2000, 16 (09) :843-844
[8]   THE MEANING AND USE OF THE AREA UNDER A RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE [J].
HANLEY, JA ;
MCNEIL, BJ .
RADIOLOGY, 1982, 143 (01) :29-36
[9]   Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries [J].
Ho, SP ;
Britton, DHO ;
Stone, BA ;
Behrens, DL ;
Leffet, LM ;
Hobbs, FW ;
Miller, JA ;
Trainor, GL .
NUCLEIC ACIDS RESEARCH, 1996, 24 (10) :1901-1907
[10]  
Hosmer W., 2000, Applied Logistic Regression, VSecond